1:44 p.m., EST
South Africa shows us how it’s done
‘Hey J.B., when’s the collapse?’
That’s a comment often seen on any number of Jerimiah Babe’s updates; openly mocking his doom and gloom assessment.
Whether he’s at the local homeless camp in Los Angeles, or in his home next to the golf course, the question remains the same;
‘J.B., When’s the collapse?’
Sometimes his response (if he’s at home) is to turn his head to the window and say “Have you looked outside?”
A good number of American’s have become so pathetically weak, ignorant, and just (to overuse the word) plain stupid, they expect to sit on their newly built patio deck (using last year’s stimmie check) and observe the fall of the U.S. from the comforts of their own back-yard.
Of course, there are some (including this author) who are first generation Americans. Their parents and grandparents emigrated (or escaped) from communist countries.
Those people do not have to ‘wake up’; they were never asleep.
South Africa gives us the model for what’s in store … at least for sections of the U.S.; probably starting first with the blue sates (we’ll see).
You might say, it’s already happening in Portland.
One news item of note shown in this report from South Africa, is neighborhood patrols.
If that’s coming our way, then we’ll need to get outfitted (if not already). Here’s a good place to start.
All of which, brings us to the markets.
Yesterday’s update showed how the so-called ‘bloodbath‘ was actually a set-up to go long (not advice, not a recommendation).
It didn’t take long for bonds (TLT) to give a Weis method ‘buy signal’. That happened at the open today.
The bull move in bonds does not confirm the ‘re-opening’ hype. That in itself, should be all that’s needed to make decisions.
It is interesting to note; on sites like ZeroHedge, there’s no talk whatsoever that biotech has (already) reversed and is leading the way down.
As of this post, inverse biotech fund LABD, is up about 38%, from its lows of late June. It appears poised for yet another breakout; lower for SPBIO and higher for LABD.
Charts by StockCharts
Note: Posts on this site are for education purposes only. They provide one firm’s insight on the markets. Not investment advice. See additional disclaimer here.